HISTORY, DEVELOPMENT AND CORPORATE STRUCTURE

(k) Round 8 Cayman Investment. On December 17, 2015, our Company entered into
a series C convertible preferred shares purchase agreement with, among others,
Suzhou Industrial Park (the “Round 8 Cayman Investor”) pursuant
to which
Suzhou Industrial Park agreed to subscribe for a total of 2,072,539 Series C
Preferred Shares at a price of US$7.2375 per share for a total consideration of
US$15 million. The allotment of the Series C Preferred Shares was completed on
December 17, 2015.

(l) Round 4 JV Investment. On August 19, 2016, Innovent Suzhou entered into a
capital increase agreement with Future Industry, Shenzhen Ping’an, Beijing Jun Lian
and Shanghai Sa Wang (together the “Round 4 JV Investors”) and Innovent HK,
pursuant to which (i) the Round 4 JV Investors agreed to contribute to Innovent
Suzhou, US$120 million, US$6,491,735 of which would be invested as the
registered capital of Innovent Suzhou (with the remaining funds allocated to the
capital reserve of Innovent Suzhou); (ii) as a result of such capital contributions by
the Round 4 JV Investors and Innovent HK, the registered capital of Innovent
Suzhou would increase from US$33,407,572 to US$47,196,802. The capital
contributions by the Round 4 JV Investors and Innovent HK were completed on
October 18, 2016.

(m) Round 9 Cayman Investment. On August 19, 2016, our Company entered into a
series D convertible preferred shares purchase agreement with, among others, LC
Healthcare, Highsino, TLS Beta, Hillhouse INOV and Cowin China (together the
“Round 9 Cayman Investors”) pursuant to which the Round 9 Cayman Investors
agreed to subscribe for a total of 5,245,845 Series D Preferred Shares at a price of
US$12.20 per share for a total consideration of US$64 million. The allotment of the
Series D Preferred Shares was completed on September 26, 2016.

(n) Round 5 JV Investment. On November 30, 2016, Innovent Suzhou entered into a
capital increase agreement with China Life, Taikang, Shanghai Chiyi and Jiaxing
Xiang’an (together the “Round 5 JV Investors”) and Innovent HK pursuant to
which (i) the Round 5 JV Investors agreed to contribute to Innovent Suzhou US$78
million, US$4,219,627 of which would be invested as the registered capital of
Innovent Suzhou (with the remaining funds allocated to the capital reserve of
Innovent Suzhou); (ii) as a result of such capital contributions by the Round 5 JV
Investors and Innovent HK,
the registered capital of Innovent Suzhou would
increase from US$47,196,802 to US$52,464,750. The capital contributions by the
Round 5 JV Investors and Innovent HK were completed on January 18, 2017.

(o) Round 10 Cayman Investment. On January 30, 2018, our Company entered into a
(as amended and
series E convertible preferred shares purchase agreement
supplemented) with, among others, investment holding companies of Capital Group
Private Markets (together the “Round 10 Cayman Investors”), pursuant to which
the Round 10 Cayman Investors agreed to subscribe for a total of 6,706,409 Series
E Preferred Shares at a price of US$13.42 per share for a total consideration of
US$90 million. The allotment of the Series E Preferred Shares was completed on
January 31, 2018.

– 198 –

